×
Please support independent journalism!
Already a subscriber? Please log in below. New to us? Please choose one of our offers and Get Started to become a subscriber.
Please support independent journalism!
Your current subscription does not provide access to this content.
All Access on your computer, phone & tablet
Replica Edition (PDF version)
Replica Edition (PDF version)
All Access on your computer, phone & tablet
Replica Edition (PDF version)
Letters to the editor for April 14, 2021 newsadvance.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsadvance.com Daily Mail and Mail on Sunday newspapers.
Only Pfizer’s COVID-19 vaccine has been approved for use in 16- and 17-year-olds, although a medical officer with the city health department said the risk level for the teen who got the vaccine was likely low.
Violent crimes have increased in Billings this past year. There were 22 homicides in 2020, Chief St. John says that s more than a 100% increase from their most violent year
MitoChem Therapeutics, Inc.: MitoChem Therapeutics Granted FDA Orphan Drug Designation for Treatment of Retinitis Pigmentosa
CHARLESTON, SC / ACCESSWIRE / April 14, 2021 / MitoChem Therapeutics, Inc., a privately held company developing therapies for diseases involving mitochondrial dysfunction, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation status to its lead compound, MC16, for treatment of retinitis pigmentosa (RP). Retinitis pigmentosa is an inherited degenerative disease of the retina caused by genetic mutations that lead to severe vision loss and blindness. There are currently no approved treatments for RP.
One of the key challenges of developing a treatment for RP is that it is not caused by a single mutation but is a composition of related diseases caused by hundreds of different genetic mutations. One of the hallmarks of retinal degeneration is mitochondrial dysfunction. Mitochondria, the powerhouse of the cell, produ